GSK: Result Summary for 113079

Result Summary for 113079

Result Summary
Protocol ID:	113079
Clinical Study ID:	ROR113079
Official Title:	Clinical evaluation of ropinirole IR (immediate release) tablets in patients who are diagnosed with symptomatic restless legs syndrome (RLS) associated with Chronic kidney disease (CKD) managed with haemodialysis (including haemofiltration and haemodiafiltration)
Phase:	phase 2
Study Indications or Diseases:	Restless Legs Syndrome
Generic Name:	ropinirole
Trade/Product Name:	Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	This study has not been published in the scientific literature.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.